Written question asked by Oliver Letwin (Conservative) on Tuesday, 8 November 2005, in the House of Commons. It was due for an answer on Thursday, 10 November 2005. It was answered by Liam Byrne (Labour) on Wednesday, 23 November 2005 on behalf of the Department of Health.
Myalgic Encephalomyelitis
- Question
- To ask the Secretary of State for Health if she will make a statement about the funding of genetic research into myalgic encephalomyelitis.
- Answer
-
The main agency through which the Government support medical and clinical research is the Medical Research Council (MRC). The MRC is an independent body funded by the Department of Trade and Industry via the Office of Science and Technology.The MRC does not normally allocate funds to particular topics: research proposals in all areas compete for the funding available. When appropriate, high quality research in particular areas of strategic importance may be given priority in competition for funds, but research excellence and importance to health continues to be the primary considerations in funding decisions. The MRC always welcomes high quality applications for support into any aspect of human health and these are judged in open competition with other demands on funding.
Secondary information
- Type
- Written question
- Reference
- 439 c2115-6W;439 c2115W; 27324
- Session
- 2005-06
- Subjects
- ME/CFS Finance Research
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2013-11-25 17:39:24 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1081424
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1081424
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1081424